USPTO serial 97808575
AIMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BARRETT, LEAH N
- Law office
- TMEG LAW OFFICE 106
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with AIMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Vancouver, BC, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lisa M. Caldwell
Lisa M. Caldwell KLARQUIST SPARKMAN, LLP121 SW SALMON STREETONE WORLD TRADE CENTER, SUITE 1600PORTLAND, OR 97204-2988Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Body and beauty care cosmetics; body and beauty care cosmetics containing cannabinoids; body and beauty care cosmetics containing cannabis; body and beauty care cosmetics containing cannabis derivatives ; body creams for cosmetic purposes; body lotions for cosmetic purposes; cannabinoid oil for cosmetic purposes; cannabis oil for cosmetic purposes; cannabis-based cosmetics; CBD cosmetics | ACTIVE | — |
| 005 | menstrual symptom treatment preparations; nutraceutical dietary supplement for maintaining general health and wellbeing; nutraceutical food and beverages for general health and well-being; nutraceuticals as a sleep aid; nutraceuticals for reducing stress and fatigue; nutraceuticals for relieving anxiety; nutraceuticals for the relief of epilepsy; nutraceuticals for the relief of pain; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of pain; topical analgesic creams; Pharmaceutical preparations for the prevention of pain; pharmaceutical preparations for the prevention, treatment, or relief of pain, namely, menstrual pain, pre-menstrual pain, peri-menopausal pain, menopausal pain and post-menopausal pain; suppositories for the prevention, treatment, or relief of pain; suppositories for the prevention, treatment, or relief of pain, namely, menstrual pain; vaginal suppositories for the prevention, treatment, or relief of pain; vaginal suppositories for the prevention, treatment, or relief of pain, namely, menstrual pain, pre-menstrual pain, peri-menopausal pain, menopausal pain and post-menopausal pain; pre-menstrual, peri-menopausal, menopausal, and post-menopausal symptom treatment preparations; pharmaceutical preparations for the prevention, treatment, or relief of pain, namely, tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for the prevention, treatment, or relief of psychological disorders, namely, tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for the treatment, prevention, or relief of inflammation, muscle cramping or spasticity, namely, tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for improving sleep quality or sleep duration, namely, tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids | ACTIVE | — |
| 009 | Downloadable software in the nature of computer software or mobile application software for managing, analyzing and storing patient health or medical information to provide recommendations for products and services in the fields of health and wellbeing and to provide information about clinical trial and drug trial criteria and qualification | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 7, 2025 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 7, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 4, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Mar 4, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Dec 20, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 14, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 27, 2023 | NWAP | NEW APPLICATION ENTERED | — |